BAILLIE GIFFORD & CO - 31 Dec 2024 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Common Stock (ADAP)

Filing Manager: BAILLIE GIFFORD & CO
Reporting Manager: BAILLIE GIFFORD & CO
Security: Adaptimmune Therapeutics PLC Common Stock
Symbol: ADAP
Shares outstanding: 1,541,621,087 shares
Disclosed Ownership: 70,914,570 shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2025, 10:25:35 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	4.6%	70,914,570	70,914,570		Grant Meikle	Threshold & Transaction Reporting Manager